News
May 29, 2007 — The FDA has cleared the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System under the Humanitarian Device Exemption — it is used with embolic coils for the treatment of intracranial aneurysms. It consists of a self-expanding stent and a delivery system. The stent serves as a scaffold for embolic coils to prevent herniation of the coils into the parent vessel.
May 27, 2007
News
May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
May 27, 2007News
May 23, 2007 — InspireMD has announced this week the enrollment of 19 patients in its First in Man study in a ...
May 21, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
May 22, 2007 — Luna Innovations has announced it has received a market clearance letter in response to its 510(k) ...
May 21, 2007News
May 23, 2007 — MicroMed Cardiovascular Inc. has announced that on Monday, May 14, 2007, doctors at Freeman Hospital in ...
May 21, 2007News
May 23, 2007 — MedicalCV Inc. has announced that the United States Patent and Trademark Office ("USPTO") has issued ...
May 21, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 23, 2007 — XTENT Inc. announced positive six-month follow-up data from the CUSTOM II clinical trial, which assessed ...
May 21, 2007News
May 21, 2007 — Sanofi-aventis has announced that the FDA has approved a supplemental New Drug Application (sNDA) for the ...
May 20, 2007News
May 21, 2007 — OrbusNeich announced today it has received CE Mark approval for three interventional cardiology products ...
May 20, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
May 21, 2007 — Findings presented last week during the annual meeting of the Heart Rhythm Society in Denver indicate a common stress test, using GE Healthcare’s latest algorithm for the measurement of T-wave Alternans (TWA), can be useful in predicting sudden cardiac death, even in those without a previous heart attack or symptoms of heart failure.
May 20, 2007News
May 18, 2007 — Inverness Medical Innovations Inc. and Biosite Inc. have announced the companies have entered into a ...
May 17, 2007News
May 18, 2007 — CoreValve has announced that it has received CE Mark approval of its CoreValve Percutaneous ReValving ...
May 17, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 18, 2007 — Hansen Medical Inc. said Thursday it obtained approval in the European Union for its Sensei robotic ...
May 17, 2007News
May 18, 2007 — Medicure, a biopharmaceutical company focused on the research, development and commercialization of novel ...
May 17, 2007News
May 18, 2007 — According to a report published Thursday in the Wall Street Journal and posted on UPI, the number of ...
May 17, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now